Moderna (MRNA) Selling, General & Administrative (2018 - 2026)
Moderna (MRNA) reported Selling, General & Administrative of $216 million for Q2 2026, down 6.1% from $230 million a year earlier but up 24.9% from the prior quarter.
Moderna (MRNA) Selling, General & Administrative (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Moderna's Selling, General & Administrative came in at $965 million, down 10.1% year-over-year; for FY2025, it was $1.02 billion, down 13.3% from FY2024.
- Selling, General & Administrative has a five-year compound annual growth rate of 40.2% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $1.17 billion in FY2024 (-24.2%), $1.55 billion in FY2023 (+36.8%), $1.13 billion in FY2022 (+99.6%) and $567 million in FY2021 (+201.6%).
- Five-year quarterly Selling, General & Administrative spans a low of $168 million in Q3 2021 and a high of $470 million in Q4 2023.
- Year over year, Selling, General & Administrative has now declined in each of the last ten quarters, with an average decline of 17.5% over the last eight quarters.
- The high point for year-over-year Selling, General & Administrative in five years was Q3 2021 (growth of 250.0%); the low point was Q3 2024 (a decline of 36.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $173 million (Q1 2026), $308 million (Q4 2025) and $268 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Moderna | 85.93 Bn | 65.29 Bn | 52.00 Mn | 216.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 216.00 Mn |
| Mar 31, 2026 | 173.00 Mn |
| Dec 31, 2025 | 308.00 Mn |
| Sep 30, 2025 | 268.00 Mn |
| Jun 30, 2025 | 230.00 Mn |
| Mar 31, 2025 | 212.00 Mn |
| Dec 31, 2024 | 351.00 Mn |
| Sep 30, 2024 | 281.00 Mn |
| Jun 30, 2024 | 268.00 Mn |
| Mar 31, 2024 | 274.00 Mn |
| Dec 31, 2023 | 470.00 Mn |
| Sep 30, 2023 | 442.00 Mn |
| Jun 30, 2023 | 332.00 Mn |
| Mar 31, 2023 | 305.00 Mn |
| Dec 31, 2022 | 375.00 Mn |
| Sep 30, 2022 | 278.00 Mn |
| Jun 30, 2022 | 211.00 Mn |
| Mar 31, 2022 | 268.00 Mn |
| Dec 31, 2021 | 201.00 Mn |
| Sep 30, 2021 | 168.00 Mn |
Moderna Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MRNA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();